Developing next-generation antibody-drug conjugates for breast cancer drug delivery: hurdles and advances in the clinic
- DOI
- 10.1080/17425247.2026.2713673
- Published
- 2026-08-11
- Container
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/17425247.2026.2713673,
title = {Developing next-generation antibody-drug conjugates for breast cancer drug delivery: hurdles and advances in the clinic},
author = {Callum Chapman and Anthony Cheung and Georgina B. Armstrong and Sophia N. Karagiannis and Zahra Rattray},
year = {2026},
journal = {Expert Opinion on Drug Delivery},
doi = {10.1080/17425247.2026.2713673},
url = {https://doi.org/10.1080/17425247.2026.2713673}
}RIS
TY - JOUR TI - Developing next-generation antibody-drug conjugates for breast cancer drug delivery: hurdles and advances in the clinic AU - Callum Chapman AU - Anthony Cheung AU - Georgina B. Armstrong AU - Sophia N. Karagiannis AU - Zahra Rattray PY - 2026 JO - Expert Opinion on Drug Delivery DO - 10.1080/17425247.2026.2713673 UR - https://doi.org/10.1080/17425247.2026.2713673 ER -
APA
Chapman, C., Cheung, A., Armstrong, G. B., Karagiannis, S. N., & Rattray, Z. (2026). Developing next-generation antibody-drug conjugates for breast cancer drug delivery: hurdles and advances in the clinic. Expert Opinion on Drug Delivery. https://doi.org/10.1080/17425247.2026.2713673
Source records
- crossref · retrieved 2026-09-26T21:23:47.128Z